Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Guardant Health (GH) through the VizualStocks API.
Earnings or loss after Guardant’s reported exclusions for financing items, taxes, depreciation/amortization, stock compensation, contingent consideration and other specified items.
adjustedEbitdaRevenue from tests and service agreements with biopharmaceutical customers, including companion diagnostics, data services and referral services. It combines the issuer’s current biopharma testing and service scope.
biopharmaDataRevenueNon-GAAP gross profit divided by revenue, excluding stock-based compensation, related employer payroll taxes and intangible amortization from cost of revenue.
nonGaapGrossMarginRevenue from oncology tests delivered to clinical customers, including hospitals, cancer centers, research institutions, patients and strategic-partner laboratories. Revenue is recognized when test results are reported and reflects estimated reimbursement.
oncologyRevenueNumber of oncology tests delivered for clinical customers during the period, reported at the issuer’s rounded precision. This excludes Shield screening tests and biopharmaceutical-customer tests.
oncologyTestVolumeRevenue from Shield blood-based cancer screening tests, recognized when results are reported and subject to estimated reimbursement.
screeningRevenueNumber of Shield blood-based cancer screening tests during the period, reported at the issuer’s rounded precision. This is test volume rather than unique patients or recognized revenue.
shieldScreeningTestVolume